{"nct_id":"NCT02380313","title":"Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone","status":"WITHDRAWN","status_verified_date":"2016-10","start_date":"2015-10","start_date_type":null,"primary_completion_date":"2017-05","primary_completion_date_type":"ESTIMATED","completion_date":"2017-05","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["GSK"]}